ATE308612T1 - Als impfstoff verwendbares attenuiertes influenzavirus - Google Patents
Als impfstoff verwendbares attenuiertes influenzavirusInfo
- Publication number
- ATE308612T1 ATE308612T1 AT00951687T AT00951687T ATE308612T1 AT E308612 T1 ATE308612 T1 AT E308612T1 AT 00951687 T AT00951687 T AT 00951687T AT 00951687 T AT00951687 T AT 00951687T AT E308612 T1 ATE308612 T1 AT E308612T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccine
- virus
- influenza virus
- poly
- usable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14614599P | 1999-07-30 | 1999-07-30 | |
GBGB9917981.4A GB9917981D0 (en) | 1999-07-30 | 1999-07-30 | Viral vaccine |
PCT/GB2000/002933 WO2001009291A1 (en) | 1999-07-30 | 2000-07-28 | Attenuated influenza virus useful as vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE308612T1 true ATE308612T1 (de) | 2005-11-15 |
Family
ID=26315811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00951687T ATE308612T1 (de) | 1999-07-30 | 2000-07-28 | Als impfstoff verwendbares attenuiertes influenzavirus |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1200563B1 (de) |
JP (1) | JP2003508086A (de) |
CN (1) | CN1451038A (de) |
AT (1) | ATE308612T1 (de) |
AU (1) | AU6454700A (de) |
CA (1) | CA2380514A1 (de) |
DE (1) | DE60023708D1 (de) |
MX (1) | MXPA02001009A (de) |
WO (1) | WO2001009291A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080292658A1 (en) * | 2004-11-11 | 2008-11-27 | Emmie De Wit | Defective Influenza Virus Particles |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
CN117587038A (zh) * | 2005-10-19 | 2024-02-23 | 佛罗里达大学研究基金公司 | 能够感染犬科动物的流感病毒及其用途 |
GB2437799B (en) * | 2006-05-24 | 2008-08-13 | Univ Warwick | Defective interfering virus |
WO2010144797A2 (en) | 2009-06-12 | 2010-12-16 | Vaccine Technologies, Incorporated | Influenza vaccines with enhanced immunogenicity and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166057A (en) * | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
-
2000
- 2000-07-28 JP JP2001521986A patent/JP2003508086A/ja not_active Withdrawn
- 2000-07-28 CA CA002380514A patent/CA2380514A1/en not_active Abandoned
- 2000-07-28 AU AU64547/00A patent/AU6454700A/en not_active Abandoned
- 2000-07-28 EP EP00951687A patent/EP1200563B1/de not_active Expired - Lifetime
- 2000-07-28 CN CN00813421A patent/CN1451038A/zh active Pending
- 2000-07-28 MX MXPA02001009A patent/MXPA02001009A/es unknown
- 2000-07-28 WO PCT/GB2000/002933 patent/WO2001009291A1/en active IP Right Grant
- 2000-07-28 DE DE60023708T patent/DE60023708D1/de not_active Expired - Lifetime
- 2000-07-28 AT AT00951687T patent/ATE308612T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2001009291A1 (en) | 2001-02-08 |
JP2003508086A (ja) | 2003-03-04 |
MXPA02001009A (es) | 2002-10-31 |
CA2380514A1 (en) | 2001-02-08 |
AU6454700A (en) | 2001-02-19 |
DE60023708D1 (de) | 2005-12-08 |
EP1200563B1 (de) | 2005-11-02 |
CN1451038A (zh) | 2003-10-22 |
EP1200563A1 (de) | 2002-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Whisnant et al. | Identification of novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus | |
Goldring et al. | Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis | |
Suguitan Jr et al. | The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals | |
WO2003079757A3 (en) | Hiv therapeutic | |
EA201201356A1 (ru) | Композиция для лечения респираторных синцитиальных вирусов | |
Dowall et al. | Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity | |
DK1218545T3 (da) | Fremgangsmåder til fremstilling af oligonukleotidopløsninger | |
DK0857211T3 (da) | Stærk homolog promoter fra hamster | |
WO2004013280A3 (en) | ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING | |
NO990025D0 (no) | Hamster-EF-1<alfa> transkripsjonsregulatorisk DNA | |
BR0210839A (pt) | Sistema de recombinação, método para remover uma sequência de dna do dna cromossÈmico de uma célula ou organismo eucarióticos, organismo, cultura de célula, órgão, tecido, parte ou material de propagação transgênico, e, uso de um organismo ou de uma cultura de célula, órgão, tecido, parte ou material de propagação transgênico | |
DE60322880D1 (de) | Einfache katalytische dna-biosensoren für ionen auf grundlage von farbveränderungen | |
WO2005105829A3 (en) | Caspase-2 inhibitors and their biological applications | |
DE60327471D1 (de) | Verfahren und zusammensetzungen zur reinigung von nukleinsäure aus einer wirtszelle | |
BR9904449A (pt) | Processo para o preparo de ácido pantotênico através de amplificação de sequências de nucleotìdeos, as quais codificam a redutase de cetopantoato | |
AU2007240448A8 (en) | Methods and compositions for expressing negative-sense viral RNA in canine cells | |
ATE548454T1 (de) | Nukleinsäurewirkstoffe zur stilllegung von h19 zwecks behandlung rheumatoider arthritis | |
Lim et al. | Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro | |
Haque et al. | Chromatin and splicing | |
HUP0302593A2 (hu) | Önállóan replikálódó RNS molekula hepatitis C vírusból | |
Nobile et al. | DNA methylation, mechanisms of FMR1 inactivation and therapeutic perspectives for fragile X syndrome | |
HUP0301869A2 (hu) | DNS-tisztítási eljárások és a tisztított DNS | |
ATE308612T1 (de) | Als impfstoff verwendbares attenuiertes influenzavirus | |
DE60331758D1 (de) | Neue vollständige genomische rna des japanenzephalitis-virus, infektiöse jev cdna daraus und deren verwendung | |
Danker et al. | Developmental information but not promoter activity controls the methylation state of histone H3 lysine 4 on two photosynthetic genes in maize |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |